Inhibition of Skp2 enhances doxorubicin‐induced cell death in B cell precursor acute lymphoblastic leukemia
Sign Up to like & getrecommendations! Published in 2022 at "Cell Biology International"
DOI: 10.1002/cbin.11779
Abstract: S‐phase kinase‐associated protein 2 (Skp2) is a well‐defined component of the Skp2‐Culin1‐F‐box (SCF) E3 ubiquitin ligase complex, which is involved in cell cycle progression and considered a prognostic marker in cancers. Overexpression of Skp2 is… read more here.
Keywords: inhibition skp2; cell; skp2; lymphoblastic leukemia ... See more keywords